Grifols (GRFS) Completes Acquisition of Talecris Biotherapeutics

Grifols, S.A. (NASDAQ: GRFS) announced that on June 1, 2011, Grifols completed its acquisition of Talecris Biotherapeutics Holdings Corp. In partial consideration for their shares, Talecris shareholders received Grifols non-voting shares that trade in the U.S. as Grifols ADSs. These new Grifols ADSs are listed on the NASDAQ Stock Exchange under the symbol "GRFS."

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Real and RE/MAX Holdings receive court approval for merger
• Denarius Metals acquires 15% stake in Copper Giant, Trafigura invests
• BIGG Digital Assets to rename as Surge Digital, consolidate shares